Alexandria Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-759
Closed -$111K 621
2017
Q3
$111K Hold
759
0.03% 177
2017
Q2
$99K Sell
759
-2
-0.3% -$245 0.03% 180
2017
Q1
$95K Hold
761
0.02% 182
2016
Q4
$88K Sell
761
-483
-39% -$53.8K 0.02% 181
2016
Q3
$130K Buy
1,244
+528
+74% +$57.1K 0.02% 172
2016
Q2
$71K Buy
716
+12
+2% +$1.24K 0.01% 215
2016
Q1
$70K Sell
704
-1
-0.1% -$103 0.01% 219
2015
Q4
$84K Buy
705
+503
+249% +$58.2K 0.02% 201
2015
Q3
$22K Buy
202
+128
+173% +$15.9K 0.01% 325
2015
Q2
$9K Sell
74
-52
-41% -$5.95K ﹤0.01% 444
2015
Q1
$15K Buy
126
+47
+59% +$5.62K 0.01% 342
2014
Q4
$9K Sell
79
-3
-4% -$316 ﹤0.01% 392
2014
Q3
$8K Sell
82
-66
-45% -$5.96K ﹤0.01% 391
2014
Q2
$13K Buy
148
+76
+106% +$5.78K 0.01% 336
2014
Q1
$5K Sell
72
-28
-28% -$2.22K ﹤0.01% 464
2013
Q4
$8K Hold
100
﹤0.01% 394
2013
Q3
$8K Hold
100
﹤0.01% 398
2013
Q2
$6K Buy
+100
New +$6.02K ﹤0.01% 468

Other funds holding CELG

Alexandria Capital's CELG Position: Q4 2017 in Review

Alexandria Capital sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 759 shares — an estimated $111K sold.

Alexandria Capital first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $130K in Q3 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Alexandria Capital reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 759 Celgene Corp shares in Q4 2017, an estimated $111K.
  • Alexandria Capital first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Alexandria Capital's Celgene Corp position peaked at $130K in Q3 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.